Consultation responses

Experts drawn from the HealthSense committee and membership have responded to government consultations on topics relevant to our aims and expertise.

This table records HealthSense's responses to public consultations, with outcomes as available (last updated 08 March 2024):

Consultation Due Submitted Outcome
PSA consultation on the future of the Accredited Registers programme 18/02/2021 14/02/2021
Report published July 2021. HW response quoted in one section of the report.
UK National Screening Committee: public involvement 13/12/2020 05/12/2020 Results published 27th January 2022.
NICE: update of guidelines for elective caesarean section 26/11/2020 28/11/2020 Update published 6th July 2021
Proposed changes to food labelling 21/10/2020 07/08/2020 Published, with updates, 13th August 2020.
NICE: prevention of fetal alcohol syndrome 18/09/2020 18/09/2020 Awaited
DHSC: proposed changes to the Human Medicine Regulations to help with the safe and efficient distribution of a COVID-19 vaccine, etc. 18/09/2020 18/09/2020 Draft Statutory Instrument written October 2020
NICE: management of chronic pain 14/09/2020 07/09/2020
Guideline published 7th April 2021. Continues to recommend acupuncture as an option in certain cases.
Competition and Markets Authority: IVF clinics 12/05/2020 06/05/2020 Final report and guidance issued 10th June 2021
DHSC: storage of embryos, eggs and sperm 05/05/2020 05/05/2020
The government had already decided that storage limits should be extended from ten years to twelve. It is unclear if any further change has been made to the regulations following this consultation.
Select Committee on Health & Social Care: NHS services during the pandemic 27/04/2020 25/04/2020
Report published 1 October 2020. No mention of breast cancer screening or AgeX.
MHRA Relationship with the public 07/10/2019 30/08/2019 Unknown – report delayed by Covid-19
European Medicines Agency Regulatory Science to 2025 (June 2019) 30/06/2019 28/06/2019
Report of strategy published March 2020. The EMA clearly had its own agenda and much of what is in the report reflects this. There is some mention of medical device regulation, e.g. where the report says that they wish to "[c]reate a process to consult medical device authorities and/or notified bodies (as applicable) for device-related aspects throughout the product lifecycle, including post-authorisation safety related events".
NHS England Implementing the Long-Term NHS Plan: Proposals for Possible Changes to Legislation 25/04/2019 N/A
Awaited. No date of publication of outcome mentioned on website but there is an invitation to sign up for updates.
Cancer screening review (Richards) 18/04/2019 18/04/2019
Interim report published May 2019. No mention of concerns about breast cancer screening or the shortcomings of the AgeX Trial.
Research integrity concordat 05/04/2019 05/04/2019
Awaited. Email sent to their office on 7th September 2019 asking for an update.
NICE consultation on shared decision-making 09/02/2021 09/02/2021 New guideline published 17/06/2021.
DHSC consultation on the appointment of Patient Safety Commissioner 05/08/2021 03/08/2021
Results of consultation published autumn 2021 and updated 6th January 2022. Most of HW's recommendations are in line with what is in the final report.
Parliamentary Science & Tech Committee consultation on research integrity and reproducibility 30/09/2021 29/09/2021
Online consultation closed 30th September 2021. Taking of evidence from oral hearings is still ongoing.
MHRA consultation on the future regulation of medical devices 25/11/2021 24/11/2021 Awaited.
NICE Twin and triplet pregnancy: progesterone for preventing preterm birth 13/02/2024 11/02/2024 Awaited
NICE Consultation on updating guidelines for the management of the menopause 05/01/2024 05/01/2024 Awaited